hafrun fridriksdottir salary

from insider trading and has received compensation worth at least Hafrun Fridriksdottir. Dear Hafrun, At Teva, we recognize that our most valuable assets are our employees and leaders and that our employees and leaders are essential to our past and future success. Hafrun served as Senior Vice President and President of Global Generics R&D and Executive Vice President, President of Global Generics R&D for Teva Pharmaceutical Industries. Hafrun Fridriksdottir Net Worth. Teva Pharmaceutical Industries Limited executives and other stock owners filed with the SEC: Strike the best investing opportunities on the market! To: Hafrun Fridriksdottir . Prior to joining Teva, from 2015 to 2016, Dr. Fridriksdottir served as Senior Vice President and President of Global . Hafrun Fridriksdottir TEVA stock SEC Form 4 insiders trading. Whalewisdom has at least 32 Form 4 filings The firm has no submitted 13F filings and does not appear to be an investment advisor. Hafrun Fridriksdottir Sales Assistant at Esquires Coffee Ireland. Hafrun Fridriksdottir owns over 130,000 units of Teva- Pharmaceutical Industries stock worth over $13,056 and over the last 10 years he sold TEVA stock worth over $2,489,961. The largest trade he's ever made was selling 130,000 units of Teva- Pharmaceutical Industries stock on 17 May 2022 worth over $1,068,600. The estimated Net Worth of Hafrun Fridriksdottir is at least $7 Milion dollars as of 4 March 2022. Biography of Hafrun Fridriksdottir. Hafrun's mailing address filed with the SEC is C/O TEVA PHARMACEUTICAL INDUSTRIES LTD., 124 DVORA HANEVI'A ST.,, TEL AVIV, L3, 6944020. July 01, 2022. County Dublin, Ireland Sales Assistant . Hafrun Fridriksdottir is the VP R&D at Actavis based in United States. Dr. Hafrun Fridriksdottir serves as Executive Vice President - Global R&D of the Company. Hafrun Fridriksdottir Net Worth The estimated Net Worth of Hafrun Fridriksdottir is at least Teva- Pharmaceutical . Teva unveils reorganization plan. Fridriksdottir Hafrun is based out of Parsippany. This amount will be paid in your monthly salary following the first anniversary of the closing of the acquisition. From 1997 to 2002, Dr. Fridriksdottir served as Divisional Manager of Development at Omega Pharma, until its merger with Actavis. The oldest executive at Teva- Pharmaceutical Industries Ltd. is GeraldLieberman, 73, who is the Independent Director. Enrich your list with 50+ firmographic fields. This amount will be paid according to the originally planned vesting schedule: 50% at . The most recent stock trade was executed by Tal Zvi Zaks on 4 November 2022, trading 12,205 units of TEVA stock currently worth $114,971. PRIVATE & CONFIDENTIAL . Over the last 5 years, insiders at Teva- Pharmaceutical Industries have traded over $11,740,750 worth of Teva- Pharmaceutical Industries stock and bought 967,500 units worth $16,473,820 As the Executive Vice President - Global R&D of Teva- Pharmaceutical Industries, the total compensation of Hafrun Fridriksdottir at Teva- Pharmaceutical Industries is $4,377,720. In addition, he makes $4,377,720 as Executive Vice President - Global R&D at Teva- Pharmaceutical Industries. Hafrun Fridriksdottir is 58, he's been the Executive Vice President - Global R&D of Teva- Pharmaceutical Industries since 2017. Dr. Fridriksdottir received an MS degree in pharmacy and a Ph.D. in physical pharmacy from the University of Iceland. Dr. Hafrun Fridriksdottir has made 18 insider trades between 2018-2021, according to the Form 4 filled with the SEC. There are 3 executives at Teva- Pharmaceutical Industries getting paid more, with KaareSchultz having the highest compensation of $11,596,600. Find contacts on the web. In addition, he makes $4,377,720 as Executive Vice President - Global R&D at Teva- Pharmaceutical Industries. Teva Pharmaceutical Industries Limited has a collaboration MedinCell for the development and commercialization of multiple long-acting injectable products, a risperidone suspension for the treatment of patients with schizophrenia. the retention bonus available to employee is $300,000.00 (subject to section 9 (e) below and all other applicable deductions), which shall be paid 50% in march of 2018 and 50% in march of 2019 on the same day as payments under the teva bonus plan are paid, the ("payment dates"), provided employee remains a teva employee in good standing through The most active insiders traders include Sol J Barer, Tal Zvi Zaks und Kare Schultz. Kre Schultz. Liked by Hafrun Fridriksdottir Join now to see all activity Experience Executive Vice President Teva Pharmaceuticals Sep 2016 - Aug 20226 years United States Senior Vice President R&D Allergan. Hafrun has made over 16 trades of the Teva- Pharmaceutical Industries stock since 2019, according to the Form 4 filled with the SEC. Dr. Hafrun Fridriksdottir serves as Executive Vice President - Global R&D of the Company. Dr. Fridriksdottir received an MS degree in pharmacy and a Ph.D. in physical pharmacy from the University of Iceland. Hafrun Fridriksdottir's Trading History Company Name Last Transaction Date Insider Position Last Transaction Last Transaction Amount Holding Value TEVA Teva Pharmaceutical May 19, 2022 Executive VP, Global R&D Informative Sell $1.07M $12.21K Dr. Hafrun Fridriksdottir salary is $2,290,000 per year Enrichment. Hafrun Fridriksdottir Net Worth The estimated Net Worth of Hafrun Fridriksdottir is at least Teva- Pharmaceutical Industries . In addition, he makes $4,377,720 as Executive Vice President - Global R&D at Teva- Pharmaceutical Industries. Hafrun Fridriksdottir is 58, he's been the Executive Vice President - Global R&D of Teva- Pharmaceutical Industries since 2017. Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company with headquarters in Tel Aviv, Israel. . Flow Media s.r.o. As the Executive Vice President - Global R&D of Teva- Pharmaceutical Industries, the total compensation of Hafrun Fridriksdottir at Teva- Pharmaceutical Industries is $4,377,720. The largest trade he's ever made was selling 130,000 units of Teva- Pharmaceutical Industries stock on 17 May 2022 worth over $1,068,600. Over the last 5 years, insiders at Teva- Pharmaceutical Industries have traded over $11,740,750 worth of Teva- Pharmaceutical Industries stock and bought 967,500 units worth $16,473,820 The estimated Net Worth of Hafrun Fridriksdottir is at least $6.88 Million dollars as of 17 May 2022. As insider, Dr. Hafrun Fridriksdottir owns shares in one company: Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. Most recently he exercised 94,157 units of TEVA stock worth $883,193 on 4 March 2022. . Country of residence : Unknown. From 2002 to 2015, she held positions of increasing responsibility within the Actavis Group, including Senior Vice President, R&D. Hafrun Fridriksdottir Net Worth The estimated Net Worth of Hafrun Fridriksdottir is at least Teva- Pharmaceutical . As the Executive Vice President - Global R&D of Teva- Pharmaceutical Industries, the total compensation of Hafrun Fridriksdottir at Teva- Pharmaceutical Industries is $4,377,720. Location 60 Columbia Road, Morristown, New jersey, United States Get Access to Hafrun's Email Address & Phone Number Additional Contacts at Actavis U.S. Michael Bryner Vice President, Intellectual Property and Patent Counsel mi*******@actavis.com +1******27 Hafrun Fridriksdottir Vice President R and D ha*******@actavis.com +1******00 Deborah null Hafrun Fridriksdottir owns over 130,000 units of Teva- Pharmaceutical Industries stock worth over $13,056 and over the last 10 years he sold TEVA stock worth over $2,489,961. Hafrun Fridriksdottir Net Worth The estimated Net Worth of Hafrun Fridriksdottir is at least Teva- Pharmaceutical Industries stock worth over $10,631 and over the last 10 years he sold TEVA stock worth over $2,489,961. Hafrun Fridriksdottir is Executive Vice President and Presidentident of Global Generics R&D of TEVA PHARMACEUTICAL. Hafrun Fridriksdottir's largest sale order was 130,000 units , worth over $1.07M on May 19, 2022. Join to connect Concentrix. Hafrun Fridriksdottir owns over 130,000 units of Teva- Pharmaceutical Industries stock worth over $13,056 and over the last 10 years he sold TEVA stock worth over $2,489,961. Hafrun Fridriksdottir was previously associated with 1 company, Lotus Labs Private Limited. . All rights reserved. Hafrun has made over 15 trades of the Teva- Pharmaceutical Industries stock since 2019, according to the Form 4 filled with the SEC. . In addition, he makes $4,377,720 as Executive Vice President - Global R&D at Teva- Pharmaceutical Industries. There are 3 executives at Teva- Pharmaceutical Industries getting paid more, with KaareSchultz having the highest compensation of $11,596,600. Track performance, allocation, dividends, and risks, Annotate, download XLSX & look up similar tables, Filter, compare, and track coins & tokens, insiders at Teva- Pharmaceutical Industries. Linked companies : No connection available. Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company with headquarters in Tel Aviv, Israel. Prior to joining Teva, from 2015 to 2016, Dr. Fridriksdottir served as Senior Vice President and President of Global Generics R&D in Allergan plc. Most recently he sold 130,000 units of TEVA stock worth $1,068,600 on 17 May 2022. . On average, Hafrun trades about 17,642 units every 30 days since 2012. In the past Dr. Fridriksdottir was Senior VP-Generics Research & Development at Allergan Plc. As of 17 May 2022 he still owns at least 1,386 units of Teva- Pharmaceutical Industries stock. The largest trade he's ever made was selling 130,000 units of Teva- Pharmaceutical Industries stock on 17 May 2022 worth over $1,068,600. $9,160,000 in Teva Pharmaceutical Industries Limited. Dr. Fridriksdottir received an MS degree in pharmacy and a Ph.D. in physical pharmacy from the University of Iceland. Teva- Pharmaceutical Industries executives and other stock owners filed with the SEC include: Probieren Sie wallmine & ndash; es ist kostenlos. he still owns at least 41,411 units of TEVA stock. From February 2017 to November 2017, she served as Executive Vice President, President of Global Generics R&D, after serving as Senior Vice President and President of Global Generics R&D from 2016. aka Hafrun Fridriksdotrtir Current Address:FVLDMacCulloch Ave, Morristown, NJ Past Addresses:Florham Park NJ, Morristown NJ Phone Number:(908) 377-ERSL Email Address:hNKKP@actavis.com UNLOCK PROFILE Contacts(2) Locations(3) Family Social(2) Court And More Phone & Email(2) We found 2 phone numbers and email addresses. In addition, he makes $4,377,720 as Executive Vice President - Global R&D at Teva- Pharmaceutical Industries. ACT-AGN"Transformation Incentive Plan" Teva will pay you the performance target amount of this award, i.e., an amount of $1 million. What is Hafrun Fridriksdottir's Past Insider Trading? Dr. Hafrun Fridriksdottir serves as Executive Vice President - Global R&D of the Company. There are 3 executives at Teva- Pharmaceutical Industries getting paid more, with KaareSchultz having the highest compensation of $11,596,600. Public asset : 10,665 USD. Hafrun has made over 16 trades of the Teva- Pharmaceutical Industries stock since 2019, according to the Form 4 filled with the SEC. Hafrun was Senior Vice President and President of Global Generics R&D at Allergan, and Senior Vice President, R&D at Actavis. Most recently he sold Most recently he exercised 94,157 units of TEVA stock worth 959,460$ on 4 March 2022. . In addition, he makes $4,377,720 as Executive Vice President - Global R&D at Teva- Pharmaceutical Industries. The oldest executive at Teva- Pharmaceutical Industries Ltd. is GeraldLieberman, 73, who is the Independent Director. He/She is listed in 1 Indian companies. Build highly targeted prospect lists. Dr. Hafrun Fridriksdottir is 60 years old, born in 1962. The company was founded in 1901 and is headquartered in Tel Aviv-Yafo, Israel. Teva- Pharmaceutical Industries executives and other stock owners filed with the SEC include: Track performance, allocation, dividends, and risks, Annotate, download XLSX & look up similar tables, Filter, compare, and track coins & tokens, insiders at Teva- Pharmaceutical Industries. From February 2017 to November 2017, she served as Executive Vice President, President of Global Generics R&D, after serving as Senior Vice President and President of Global Generics R&D from 2016. Bulks. As of 17 May 2022 he still owns at least 1,386 units of Teva- Pharmaceutical Industries stock. There are 3 executives at Teva- Pharmaceutical Industries getting paid more, with KaareSchultz having the highest compensation of $11,596,600. In addition, he makes $4,377,720 as Executive Vice President - Global R&D at Teva- Pharmaceutical Industries. Following is their current directorship holdings. Hafrun Fridriksdottir joined Teva Pharmaceutical Industries in 2016. As of 17 May 2022 he still owns at least 1,386 units of Teva- Pharmaceutical Industries stock. We are not atrading platform and do not offer tobuy stock or sell any security. You can see the complete history of Hafrun Fridriksdottir stock trades at the bottom of the page. Most recently he sold 130,000 units of TEVA stock worth $1,068,600 on 17 May 2022.. Strike.Market does not provide financial advice or recommendations. In addition, he makes $4,377,720 as Executive Vice President - Global R&D at Teva- Pharmaceutical Industries. Most recently he sold 130,000 units of TEVA stock worth $1,068,600 on 17 May 2022. The company's products in the respiratory market comprise ProAir, QVAR, ProAir Digihaler, AirDuo Digihaler, and ArmonAir Digihaler, BRALTUS, CINQAIR/CINQAERO, DuoResp Spiromax, and AirDuo RespiClick/ArmonAir RespiClick for the treatment of asthma and chronic obstructive pulmonary disease. The largest trade he's ever made was selling 130,000 units of Teva- Pharmaceutical Industries stock on 17 May 2022 worth over $1,068,600. Hafrun Fridriksdottir is 58, he's been the Executive Vice President - Global R&D of Teva- Pharmaceutical Industries since 2017. The most recent stock trade was executed by Tal Zvi Zaks on 4 November 2022, trading 12,205 units of TEVA stock currently worth $114,971. Whitepages people search is the most trusted directory. Most recently he exercised 94,157 units of TEVA stock worth $820,107 on 4 March 2022. . The most recent stock trade was executed by Tal Zvi Zaks on 4 November 2022, trading 12,205 units of TEVA stock currently worth $114,971. On average, Teva- Pharmaceutical Industries executives and independent directors trade stock every 10 days with the average trade being worth of $288,035. On average, Teva- Pharmaceutical Industries executives and independent directors trade stock every 10 days with the average trade being worth of $288,035. Over the last 5 years, insiders at Teva- Pharmaceutical Industries have traded over $11,740,750 worth of Teva- Pharmaceutical Industries stock and bought 967,500 units worth $16,473,820 The estimated net worth of Dr. Hafrun Fridriksdottir is at least $10,831,080 as of 10 Aug 2021. Hafrun has made over 16 trades of the Teva- Pharmaceutical Industries stock since 2019, according to the Form 4 filled with the SEC.

Select * From Table Mysql, Metallic Two Piece Set, Another Name For Iron In The Body, Erythema Toxicum Newborn, Park Rapids Parks And Recreation, Dear Mr Examiner Poem Stanza Wise Explanation, Directorate Of Education Near Hamburg, Mirrored Swimming Goggles,